[wpseo_breadcrumb]

After receiving a COVID-19 vaccine, you’ll be given a vaccine card. If you receive a two-dose vaccine, you should receive your card after your first dose, which will be updated upon your second dose.

According to the Centers for Disease Control and Prevention (CDC), this card tells you which vaccine you received, how many doses, the date(s) you received it and where you received it. When you receive this card, you may be wondering what its purpose is, what you’ll need it for and what you should do with it. Here’s what you need to know.

[wpseo_breadcrumb]

Vaccinations are a critical way to keep yourself and the public at large healthy.

However, vaccinations often come with questions, particularly for new diseases. This article helps answer some of those questions, compiling expert guidance from the Centers for Disease Control and Prevention (CDC).

Before Getting Your Vaccine

It’s important to know whether the COVID-19 vaccination is recommended for you before making any further decisions. This CDC webpage explains who should be vaccinated first. Use the link to see the specific rollout timeline for your state, as it will vary by location. It’s also worth doing a little research on the available vaccines, including how they work and their benefits.

News Brief header The Centers for Disease Control and Prevention (CDC) has released new guidance for people who have been fully vaccinated with a COVID-19 vaccine.

Such individuals have been given the go-ahead to resume many activities that have been on hold since the beginning of the pandemic.

What’s Changed

According to the CDC, people are considered fully vaccinated two weeks after their second dose in a two-dose series, like the Pfizer-BioNTech or Moderna vaccines, or two weeks after a single-dose vaccine, like Johnson & Johnson’s vaccine. According to the guidance, people who have been fully vaccinated:

News Brief header President Joe Biden recently announced that he is directing the U.S. Department of Health and Human Services to purchase an additional 100 million doses of the Johnson & Johnson COVID-19 vaccine.

The White House had announced earlier in March that drugmaker Merck & Co. will help produce competitor Johnson & Johnson’s COVID-19 vaccine to expand its production and supply. The administration invoked the Defense Production Act to get two Merck facilities up to the standards necessary to safely manufacture the Johnson & Johnson vaccine. However, it will take months to fully equip these plants.